Location [1]
Protein [2]
Synonyms [1]
NAPB, PNUTL4, AF17q25, SINT1, MSF1, MSF, SeptD1

SEPT9 is altered in 0.06% of all cancers with colon adenocarcinoma, endometrial endometrioid adenocarcinoma, acute myeloid leukemia, breast invasive ductal carcinoma, and colorectal mucinous adenocarcinoma having the greatest prevalence of alterations [3].

SEPT9 GENIE Cases - Top Diseases

The most common alterations in SEPT9 are SEPT9 A100T (0.85%), SEPT9 A571S (0.39%), SEPT9 E393Q (0.22%), SEPT9 I114M (0.85%), and SEPT9 I397V (0.22%) [3].

SEPT9 GENIE Cases - Top Alterations


1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.